Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zimmermann

Showing results (71-80 of 279) with videos related to

Pageof 28
Sort By:
Blood|January 10, 2008
Treatment and prognostic impact of transient leukemia in neonates with Down syndromeJan-Henning Klusmann, Ursula Creutzig, Martin Zimmermann, et al.
Leukemia Research|May 20, 2011
Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemiaSeisho Takeuchi, Masahide Matsushita, Martin Zimmermann, et al.
Haematologica|August 3, 2019
Methotrexate-associated toxicity in children with Down syndrome and acute lymphoblastic leukemia during consolidation therapy with high dose methotrexate according to ALL-BFM treatment regimenMirko Kroll, Kirsten Kaupat-Bleckmann, Anja Mörickel, et al.
British Journal of Haematology|September 18, 2007
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphomaGeorg Mann, Andishe Attarbaschi, Birgit Burkhardt, et al.
Chembiochem : a European Journal of Chemical Biology|February 3, 2006
The ether lipid inositol-C2-PAF is a potent inhibitor of cell proliferation in HaCaT cellsAnnette Fischer, Dieter Müller, Martin Zimmermann-Kordmann, et al.
Haematologica|September 26, 2008
Anemia and survival in childhood acute lymphoblastic leukemiaOliver Teuffel, Martin Stanulla, Gunnar Cario, et al.
British Journal of Haematology|March 17, 2010
Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline dosesUrsula Creutzig, Martin Zimmermann, Michael Dworzak, et al.
British Journal of Haematology|January 21, 2010
Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendationsHeidrun Gerr, Martin Zimmermann, Martin Schrappe, et al.
Blood|January 21, 2006
Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter TrialIlske Oschlies, Wolfram Klapper, Martin Zimmermann, et al.
Leukemia|March 19, 2018
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012Mareike Rasche, Martin Zimmermann, Lisa Borschel, et al.
Pageof 28

Showing results (71-80 of 279) with videos related to

Sort By:
Pageof 28
Blood|January 10, 2008
Treatment and prognostic impact of transient leukemia in neonates with Down syndromeJan-Henning Klusmann, Ursula Creutzig, Martin Zimmermann, et al.
Leukemia Research|May 20, 2011
Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemiaSeisho Takeuchi, Masahide Matsushita, Martin Zimmermann, et al.
Haematologica|August 3, 2019
Methotrexate-associated toxicity in children with Down syndrome and acute lymphoblastic leukemia during consolidation therapy with high dose methotrexate according to ALL-BFM treatment regimenMirko Kroll, Kirsten Kaupat-Bleckmann, Anja Mörickel, et al.
British Journal of Haematology|September 18, 2007
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphomaGeorg Mann, Andishe Attarbaschi, Birgit Burkhardt, et al.
Chembiochem : a European Journal of Chemical Biology|February 3, 2006
The ether lipid inositol-C2-PAF is a potent inhibitor of cell proliferation in HaCaT cellsAnnette Fischer, Dieter Müller, Martin Zimmermann-Kordmann, et al.
Haematologica|September 26, 2008
Anemia and survival in childhood acute lymphoblastic leukemiaOliver Teuffel, Martin Stanulla, Gunnar Cario, et al.
British Journal of Haematology|March 17, 2010
Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline dosesUrsula Creutzig, Martin Zimmermann, Michael Dworzak, et al.
British Journal of Haematology|January 21, 2010
Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendationsHeidrun Gerr, Martin Zimmermann, Martin Schrappe, et al.
Blood|January 21, 2006
Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter TrialIlske Oschlies, Wolfram Klapper, Martin Zimmermann, et al.
Leukemia|March 19, 2018
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012Mareike Rasche, Martin Zimmermann, Lisa Borschel, et al.
Pageof 28